Portfolio company
Arvada
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This drug discovery and development company creates medicines for patients with abnormal heart rhythms.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Arvada Therapeutics
This biotechnology company develops large-molecule therapeutics to treat patients suffering from abnormal heart rhythms and arrhythmogenic right ventricular cardiomyopathy.
Acesion Pharma ApS
This biotech company develops small-molecule drugs to treat atrial fibrillation by inhibiting ion channels for patients with cardiac arrhythmia.
Acesion Pharma
The company develops ion channel inhibitors to treat atrial fibrillation for patients with cardiac arrhythmia.
AnaCardio
This biopharmaceutical company develops oral small-molecule drugs to improve cardiac contractility in patients with heart failure.
Argá Medtech
This company develops non-thermal cardiac ablation systems and proprietary catheters for healthcare providers to treat atrial fibrillation and other cardiac arrhythmias.
Maxwellbiomedical
This company develops an electrical stimulation platform for patients with atrial fibrillation to restore heart rhythms and function without destroying tissue.
Brano Therapeutics
This company develops small-molecule inhibitors to treat heart failure and metabolic dysfunction for patients with cardiovascular diseases.
InCarda Therapeutics
This biopharmaceutical company develops inhaled therapies to treat patients with acute cardiovascular conditions such as paroxysmal atrial fibrillation.